Quantcast

Latest Darbepoetin alfa Stories

2010-07-26 07:00:00

EXTON, Pa., July 26 /PRNewswire/ -- BioTrends Research Group, Inc. recently published its TreatmentTrends®: US Nephrology Q2 2010 report.

2010-05-20 17:08:00

THOUSAND OAKS, Calif., May 20 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that results from studies involving nine molecules in the Company's oncology portfolio will be presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4( )- 8, 2010 in Chicago. "Cancer is a complex disease that requires a comprehensive approach.

2010-03-03 09:01:40

A new study helps dispel mounting confusion over the safety of blockbuster anemia drugs — erythropoiesis-stimulating agents — for people with kidney disease requiring dialysis, as federal regulators prepare to decide whether to impose additional restrictions on their use.

2010-02-16 10:54:00

SILVER SPRING, Md., Feb 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs).

2010-02-16 08:58:00

HORSHAM, Pa., Feb. 16 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. and Amgen Inc. today announced that the U.S.

2010-02-16 08:50:00

THOUSAND OAKS, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) and Centocor Ortho Biotech Products, L.P., today announced that the U.S.

2010-01-06 15:22:00

EXTON, Pa., Jan. 6 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the availability of its TreatmentTrends®: US Nephrology, EU Nephrology, and Canadian Nephrology publications.

2009-12-23 09:05:38

An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising.

2009-11-30 07:51:00

THOUSAND OAKS, Calif., Nov. 30 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that it will present updated long-term safety and efficacy data for Nplate® (romiplostim) in adult chronic immune (idiopathic) thrombocytopenic purpura (ITP).


Word of the Day
palinode
  • A poem in which the author retracts something said in an earlier poem.
The word 'palinode' comes from Greek roots meaning 'again' and 'song'.
Related